Primary Peritoneal Carcinoma Recruiting Phase 2 Trials for Gemcitabine (DB00441)

IndicationStatusPhase
DBCOND0028874 (Primary Peritoneal Carcinoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03783949European Trial on Enhanced DNA Repair Inhibition in Ovarian CancerTreatment